A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender - PubMed (original) (raw)
A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender
R Mayeux et al. Arch Neurol. 1992 May.
Abstract
Because the prevalence of idiopathic Parkinson's disease (PD) with or without dementia remains controversial, we initiated a population-based investigation in the Washington Heights-Inwood section of New York, NY, so that nearly complete case ascertainment could be achieved. A "registry" was developed for the study, and we advertised in periodicals and on radio and television. Subjects, or their records, were examined by experienced neurologists, and most underwent a battery of neuropsychological tests specifically designed for assessment in this community. All data were reviewed by a team of clinicians to achieve a consensus diagnosis. The crude prevalence of idiopathic PD, with and without dementia, was 99.4 per 100,000, increasing from 2.3 per 100,000 for those younger than 50 years to 1144.9 per 100,000 for those aged 80 years and older. The crude prevalence for PD with dementia alone was 41.1 per 100,000 and also increased with age from zero for those younger than 50 years to 787.1 per 100,000 for those aged 80 years and older. Prevalence ratios were comparable with those of other published population-based studies in similar settings. After standardization, men had PD with and without dementia more frequently than did women. The major difference between patients with and without dementia was a later estimated age at onset of motor manifestations. We conclude that PD is a frequent disorder in the elderly population that affects men and whites more frequently than women and nonwhites. Moreover, dementia in patients with PD is more frequent than previously recognized and is strongly related to the age at onset of motor manifestations.
Similar articles
- An estimate of the prevalence of dementia in idiopathic Parkinson's disease.
Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S. Mayeux R, et al. Arch Neurol. 1988 Mar;45(3):260-2. doi: 10.1001/archneur.1988.00520270034017. Arch Neurol. 1988. PMID: 3341950 - Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.
Hobson P, Meara J. Hobson P, et al. Mov Disord. 2004 Sep;19(9):1043-9. doi: 10.1002/mds.20216. Mov Disord. 2004. PMID: 15372593 - Parkinson disease with and without Dementia: A prevalence study and future projections.
Savica R, Grossardt BR, Rocca WA, Bower JH. Savica R, et al. Mov Disord. 2018 Apr;33(4):537-543. doi: 10.1002/mds.27277. Epub 2018 Jan 22. Mov Disord. 2018. PMID: 29356127 Free PMC article. - The epidemiology of dementia associated with Parkinson disease.
Aarsland D, Kurz MW. Aarsland D, et al. J Neurol Sci. 2010 Feb 15;289(1-2):18-22. doi: 10.1016/j.jns.2009.08.034. Epub 2009 Sep 4. J Neurol Sci. 2010. PMID: 19733364 Review. - Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.
Oertel WH. Oertel WH. Arzneimittelforschung. 1995 Mar;45(3A):386-9. Arzneimittelforschung. 1995. PMID: 7763330 Review.
Cited by
- Mitochondrial Dysfunction in Parkinson's Disease.
Moon HE, Paek SH. Moon HE, et al. Exp Neurobiol. 2015 Jun;24(2):103-16. doi: 10.5607/en.2015.24.2.103. Epub 2015 Jun 8. Exp Neurobiol. 2015. PMID: 26113789 Free PMC article. Review. - Association between presenting motor symptoms and the risk of cognitive impairment in Parkinson's disease.
Viitanen M, Mortimer JA, Webster DD. Viitanen M, et al. J Neurol Neurosurg Psychiatry. 1994 Oct;57(10):1203-7. doi: 10.1136/jnnp.57.10.1203. J Neurol Neurosurg Psychiatry. 1994. PMID: 7931381 Free PMC article. - Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States.
Willis AW, Schootman M, Kung N, Racette BA. Willis AW, et al. Parkinsonism Relat Disord. 2013 Feb;19(2):202-6. doi: 10.1016/j.parkreldis.2012.09.014. Epub 2012 Oct 17. Parkinsonism Relat Disord. 2013. PMID: 23083512 Free PMC article. - Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women.
Glatt CE, Wahner AD, White DJ, Ruiz-Linares A, Ritz B. Glatt CE, et al. Hum Mol Genet. 2006 Jan 15;15(2):299-305. doi: 10.1093/hmg/ddi445. Epub 2005 Dec 8. Hum Mol Genet. 2006. PMID: 16339215 Free PMC article. - Behavioral disturbances in Parkinson's disease.
Anderson KE. Anderson KE. Dialogues Clin Neurosci. 2004 Sep;6(3):323-32. doi: 10.31887/DCNS.2004.6.3/kanderson. Dialogues Clin Neurosci. 2004. PMID: 22033600 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical